You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma supports the 2020 Primary Immunodeficiency Week

The company stands alongside the global PI community

read more 

EVENTS

World Hemophilia Day: socially distant but still united with patients

Now more than ever, Kedrion is renewing its commitment to those who live with this rare disorder

read more 
  1. CORPORATE - 30-04-2015

    Kedrion SpA’s Shareholders approve 2014 financial statement

    A 466 million euros’ turnover with a 9,8% rise on 2013

    read more 
  2. EVENTS - 17-04-2015

    Kedrion supported the XI World Hemophilia Day

    An increasingly tailor-made prophylaxis lets sports and hemorrhagic conditions live together

    read more 
  3. CORPORATE - 27-02-2015

    Kedrion unveils its new manufacturing plant in Castelvecchio Pascoli

    The company has invested over 67 million euros and is expected to create between 70 and 90 new jobs

    read more 

Pages

For more information please contact: pressoffice@kedrion.com